OGEN

News Oragenics delays 2023 Annual Meeting - Investing.com

14d ago

SEC filing OGEN Signs LOI to License CardioDialysis™ for TBI, Targets $3.25M Share Issuance, 3% Royalty, Dual-Barrier Strategy

26d ago

SEC filing OGEN Doses First Patient in Phase IIa ONP-002 Trial for Concussion, Mackay Hospital Activated March 31, 2026, 40-Patient Study, $9B Global Concussion Market, Intranasal Delivery, CEO Janet Huffman, Dr. James Kelly, HREC Approval, Targets Q4 2026 IND Submission

50d ago

Scanner Unusual buy pressure (3.5x avg, 68% up-volume, +9.8% / +0.08 intraday, above VWAP)

88d ago

News Orix Corp Ads Q3 Earnings Call Highlights

113d ago

News Clinical Trial Demonstrates Accurate Non-Invasive Detection of In Vivo Biologic Activity in Melanomas by the Orlucent® Skin Fluorescent Imaging System

133d ago

News Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff

139d ago

News Bowman Acquires Sierra Overhead Analytics, Expands Technology-enabled Engineering Services

153d ago

SEC filing OGEN Raises CEO Janet Huffman Salary 5% to $341K, Grants 250K Stock Options

169d ago